AU2002367988A1 - Composition containing an ethyl acetate soluble extract from kalopanax pictus nakai and kalopanaxsaponin a derivatives isolated therein for protecting and treating inflammatory and rheumatic disease - Google Patents
Composition containing an ethyl acetate soluble extract from kalopanax pictus nakai and kalopanaxsaponin a derivatives isolated therein for protecting and treating inflammatory and rheumatic diseaseInfo
- Publication number
- AU2002367988A1 AU2002367988A1 AU2002367988A AU2002367988A AU2002367988A1 AU 2002367988 A1 AU2002367988 A1 AU 2002367988A1 AU 2002367988 A AU2002367988 A AU 2002367988A AU 2002367988 A AU2002367988 A AU 2002367988A AU 2002367988 A1 AU2002367988 A1 AU 2002367988A1
- Authority
- AU
- Australia
- Prior art keywords
- kalopanaxsaponin
- protecting
- ethyl acetate
- composition containing
- treating inflammatory
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 title 3
- 241000319057 Kalopanax septemlobus Species 0.000 title 1
- 208000025747 Rheumatic disease Diseases 0.000 title 1
- 208000027866 inflammatory disease Diseases 0.000 title 1
- 230000002757 inflammatory effect Effects 0.000 title 1
- KEOITPILCOILGM-LLJOFIFVSA-N kalopanaxsaponin A Chemical class O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@@H]2[C@@]([C@H]3[C@]([C@@H]4[C@@]([C@@]5(CC[C@]6(CCC(C)(C)C[C@H]6C5=CC4)C(O)=O)C)(C)CC3)(C)CC2)(C)CO)OC[C@H](O)[C@@H]1O KEOITPILCOILGM-LLJOFIFVSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Botany (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Rheumatology (AREA)
- General Chemical & Material Sciences (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020020029419A KR100555660B1 (ko) | 2002-05-27 | 2002-05-27 | 해동피의 에틸아세테이트 가용 추출물로 부터 분리된 칼로파낙스 사포닌 에이 유도체를 포함하는 관절염 예방 및 치료용 조성물 |
| KR2002/29419 | 2002-05-27 | ||
| PCT/KR2002/002296 WO2003099305A1 (fr) | 2002-05-27 | 2002-12-06 | Composition contenant un extrait soluble d'acetate d'ethyle produit a partir de kalopanax pictus nakai, et derives de kalopanaxsaponin a isoles dudit extrait pour prevenir ou traiter une maladie inflammatoire ou rhumatismale |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2002367988A1 true AU2002367988A1 (en) | 2003-12-12 |
Family
ID=29578145
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002367988A Abandoned AU2002367988A1 (en) | 2002-05-27 | 2002-12-06 | Composition containing an ethyl acetate soluble extract from kalopanax pictus nakai and kalopanaxsaponin a derivatives isolated therein for protecting and treating inflammatory and rheumatic disease |
Country Status (3)
| Country | Link |
|---|---|
| KR (1) | KR100555660B1 (fr) |
| AU (1) | AU2002367988A1 (fr) |
| WO (1) | WO2003099305A1 (fr) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100896325B1 (ko) * | 2002-06-29 | 2009-05-07 | 학교법인 상지학원 | 칼로파낙스사포닌 ｋ 및 이의 대사물 및 이를 함유한 염증및 관절염 치료제 |
| KR101321754B1 (ko) * | 2013-03-29 | 2013-10-28 | 유한회사한풍제약 | 류마티스 관절염 및 골관절염의 개선 또는 치료를 위한 조성물 |
| CN104761610A (zh) * | 2015-02-10 | 2015-07-08 | 江西本草天工科技有限责任公司 | 一类新型的α-常春藤皂苷衍生物及其制备方法和用途 |
| CN107550917B (zh) * | 2017-10-19 | 2020-04-24 | 广州博济医药生物技术股份有限公司 | 常春藤皂苷元及其衍生物或其盐在制备治疗骨性关节炎药物中的应用 |
| CN112194701B (zh) * | 2020-10-10 | 2023-03-03 | 福建师范大学泉港石化研究院 | 一种改性无患子皂苷相容剂及其制备方法与应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20020023456A (ko) * | 2000-09-22 | 2002-03-29 | 조근식 | 해동피를 주원료로 한 과립상 건강 식품 조성물 |
| KR20020071228A (ko) * | 2001-03-05 | 2002-09-12 | 연규동 | 엄나무 추출물, 이의 제조방법 및 용도 |
-
2002
- 2002-05-27 KR KR1020020029419A patent/KR100555660B1/ko not_active Expired - Fee Related
- 2002-12-06 WO PCT/KR2002/002296 patent/WO2003099305A1/fr not_active Ceased
- 2002-12-06 AU AU2002367988A patent/AU2002367988A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| KR100555660B1 (ko) | 2006-03-10 |
| KR20030091405A (ko) | 2003-12-03 |
| WO2003099305A1 (fr) | 2003-12-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LU92419I2 (fr) | Riociguat et ses dérivés pharmaceutiquement acceptables (ADEMPAS®) | |
| LU92513I2 (fr) | Sofosbuvir et ses dérivés pharmaceutiquement acceptables (solvaldi) | |
| LU92517I2 (fr) | Delamanide et ses dérivés pharmaceutiquement acceptables | |
| LU92381I2 (fr) | Macitentan et ses dérivés pharmaceutiquement acceptables (OPSUMIT) | |
| NO20022894L (no) | Oral formulering omfattende en inhibitorforbindelse av ileum- galle transport og en HMG CO-A reduktase inhibitor | |
| AU2003254099A1 (en) | Corn event pv-zmir13 (mon863) plants and compositions and methods for detection thereof | |
| EP1189895B8 (fr) | Derives de thiazol et d'oxazole et utilisation pharmaceutique de ceux-ci | |
| AU2001288474A1 (en) | Use of radiation for inhibiting hyperplasia after intravascular intervention | |
| IL162118A0 (en) | Pharmaceutical compositions containing an orally active taxane derivative | |
| AU2001294808A1 (en) | Catecholamine pharmaceutical compositions and methods | |
| LU92024I2 (fr) | Pasireotide et ses dérivés pharmaceutiquement acceptables (SIGNIFOR) | |
| LU91624I2 (fr) | Canakinumab et ses dérivés pharmaceutiquement acceptables (ILARIS®) | |
| AU2002234597A1 (en) | Branched primary alcohol compositions and derivatives thereof | |
| AU5326100A (en) | Pharmaceutical compositions and methods for use | |
| LU91882I2 (fr) | Pradofloxacin et ses dérivés pharmaceutiquement acceptables (VERAFLOX®) | |
| LU91883I2 (fr) | Pradofloxacin et ses dérivés pharmaceutiquement acceptables (VERAFLOX®) | |
| IL168477A (en) | Isoindoline derivatives and pharmaceutical compositions comprising them | |
| AU1597201A (en) | Pyrrolecarbonylimino derivatives as naaladase inhibitors | |
| IL144896A0 (en) | Pharmaceutical compositions comprising benzaldehyde derivatives and several such new compounds | |
| LU92634I2 (fr) | Flutémétamol (18f) et ses dérivés pharmaceutiquement acceptables (vizamyl) | |
| AU4456601A (en) | Oxa(thia)zolidine derivative and anti-inflammatory drug | |
| AU2003294122A1 (en) | Medicinal compositions comprising a core and a film based on modified cellulose derivatives | |
| AU4315700A (en) | N-substituted dihydropyrrole derivatives | |
| AU2002367988A1 (en) | Composition containing an ethyl acetate soluble extract from kalopanax pictus nakai and kalopanaxsaponin a derivatives isolated therein for protecting and treating inflammatory and rheumatic disease | |
| AU2001278738A1 (en) | Medicinal compositions for preventing and treating cancer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |